Electroceuticals are the new category of therapeutic agents which act by targeting the neural circuits of organs. Moreover, electroceuticals involves mapping of neural circuitry and delivering neural impulses to the specific targets. This impulse is administered via an implantable device. In cardiology besides pacemaker, defibrillation and resynchronization applications; Electroceuticals used in heart failure, atrial fibrillation, coronary artery disease, myocarditis, resistant hypertension, atrial and ventricular tachyarrhythmias, pulseless electrical activity, and refractory angina.
Market Dynamics
Electroceutical devices market is expected to witness lucrative growth opportunities during forecast period owing to the advancements in electroceutical technology, strategic collaboration, mergers and acquisitions among key players in these market. Furthermore, other potential factors contributing to the growth of electroceutical devices market include rising number of disease among geriatric population such as cardiac arrhythmias, Parkinson’s disease, Alzheimer’s disease, epilepsy, and depression, and increases in chronic diseases such as neurological, and cardiac disorders. For instance, according to the American College of Cardiology, cardiovascular disease represents great burden for the elderly population, their caregivers and the health system.
Key features of the study:
- This report provides in-depth analysis of electroceutical devices in medical sector and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global electroceutical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include Medtronic plc, Abbott Laboratories, Cochlear Ltd. Sonova Holding AG, Advanced Bionics AG, Boston Scientific Corporation, electroCore, Inc., Biotronik, ReShape Lifesciences, Inc., and LivaNova, PLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
- The global electroceutical devices market report caters to various stakeholders in this industry including investors, suppliers, electroceutical devices based product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the electroceutical devices market.
Detailed Segmentation:
- Global Electroceutical Devices Market, By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- Global Electroceutical Devices Market, By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- Global Electroceutical Devices Market, By Application:
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- Global Electroceutical Devices Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global Electroceutical Devices Market, By Geography:
- North America
- By Country:
- By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- By Application
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Europe
- By Country:
- Germany
- France
- Italy
- UK
- Spain
- Russia
- Rest of Europe
- By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- By Application
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Asia Pacific
- By Country:
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
- By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- By Application
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- By Application
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Latin America
- By Country:
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- By Application
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- Cardiac Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy Devices
- Retinal Implants
- Cochlear Implants
- Spinal cord Stimulators
- Deep brain Stimulators
- Sacral Neuromodulators
- Others
- By Modality:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
- By Application
- Chronic Pain
- Cardiovascular Diseases
- Ophthalmic Diseases
- Neurological Diseases
- Hearing Disorders
- Gastrointestinal Diseases
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Company Profiles
- Medtronic plc*
- Company Overview
- Product Type Portfolio
- Financial Performance
- Key Developments
- Strategies
- Cochlear Ltd.
- Sonova Holding AG
- Abbott Laboratories
- Advanced Bionics AG
- Boston Scientific Corporation
- ElectroCore, Inc.
- Biotronik
- ReShape Lifesciences, Inc.
- LivaNova, PLC
“*” marked represents similar segmentation in other categories in the respective section.
